NCT03569085 is a Phase 1 clinical trial of Sevoflurane in Heart Diseases, sponsored by Kathirvel Subramaniam.

Who is sponsoring NCT03569085?

NCT03569085 is sponsored by Kathirvel Subramaniam.

What drugs are being tested in NCT03569085?

Interventions in NCT03569085: Sevoflurane, Isoflurane.

What condition does NCT03569085 study?

NCT03569085 studies Heart Diseases.

Is NCT03569085 still recruiting?

NCT03569085 is currently completed. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT03569085

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inhaled Anesthetics and Myocardial Strain

Completed Phase 1 Last updated 5 October 2023

What this trial tests

Phase 1 trial testing Sevoflurane in Heart Diseases in 26 participants. Completed in 4 May 2023.

Timeline

27 June 2018

Primary endpoint
6 December 2018

4 May 2023

Quick facts

Lead sponsor	Kathirvel Subramaniam
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	26
Start date	27 June 2018
Primary completion	6 December 2018
Estimated completion	4 May 2023
Sites	1 location across United States

Drugs / interventions tested

Sevoflurane — full drug profile →
Isoflurane (ISOFLURANE) — full drug profile →

Conditions studied

Heart Diseases — all drugs for Heart Diseases →

Sponsor

Kathirvel Subramaniam — full company profile →

Who can join

18 and older, any sex, with Heart Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Speckle tracking imaging measuring software will be used for offline analysis of transesophageal echocardiogram (TEE) -acquired images of the left ventricle(LV) in four chambers(4C), two chambers (2C) and long axis (LAX) views to calculate global longitudinal strain (GLS) of LV for comparisons between sevoflurane and isoflurane at the same minimum alveolar concentration ( MAC) levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

NCT07525648 — Comparison of the Effects of Sevoflurane and Desflurane on Optic Nerve Sheath Diameter During Laparoscopic Surgery · NA · recruiting
NCT07511634 — Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Cont · NA · not yet recruiting
NCT07440758 — Low-Flow Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy · NA · not yet recruiting
NCT07295158 — Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy · NA · recruiting
NCT07152912 — Impact of Isoflurane and Sevoflurane on Oxidative Stress in Patients Undergoing Laparoscopic Cholecystectomy · NA · recruiting

Other recruiting trials for Heart Diseases

Currently open trials in the same condition.

NCT07288216 — Transition to KPL-387 Monotherapy Dosing & Administration Study · Phase 2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
NCT06769880 — Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Fa · NA · recruiting

Other Kathirvel Subramaniam trials

Trials by the same sponsor.

NCT03270514 — Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride · Phase 3 · completed
NCT03198871 — IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03569085 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kathirvel Subramaniam
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03569085.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing